Sponsored Research
Christopher Holley of Cardiology has received an award from the UH Harrington Discovery Institute for a project entitled "Targeting snoRNAs to Treat Atherosclerosis." Total funding will be $100,000.
Manesh Patel of Cardiology has received an award (4UH3-HL165017-02) from the National Institutes of Health for a project entitled "1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)." Total funding will be $8,214,691.
Kalyani Kottilil (Mentor: Svati Shah) of Cardiology has received an award (1F31-HL175914-01) from the National Institutes of Health for a project entitled "Integrative 'omics for biomarkers and biology of early-stage heart failure." Total funding will be $97,948.
Jie Wang of Cell Therapy has received an award from the University of Michigan for a project entitled "Phase 2, open label, multicenter study of pacritinib in relapsed/refractory T-cell lymphoproliferative neoplasms." Total funding will be $51,047.
Heather Whitson of Geriatrics has received an award from the Alzheimer's Association for a project entitled "Unveiling the Neurovascular Responses to Amyloid-Beta Antibodies: A Neurovascular Unit-on-a-Chip Approach for Personalized Passive Immunotherapy." Total funding will be $148,409.
Sanjay Khandelwal of Hematology has received an award (HT94252410597) from the Department of Defense for a project entitled "Complement activating properties of anti-Sm/RNP antibodies in SLE." Total funding will be $300,000.
Charity Oyedeji of Hematology has received an award (3K01-HL166369-02S1) from the National Institutes of Health for a project entitled "Sickle Cell Disease Functional Assessment Validation and Exercise Pilot Intervention." Total funding will be $72,814.
James White of Hematology has received an award (1R21-AG086701-01A1) from the National Institutes of Health for a project entitled "Heterochronic hepatocyte transplantation to rejuvenate the aged liver." Total funding will be $442,750.
Jason Stout of Infectious Diseases has received an award from the NC DHHS for a project entitled "Epidemiology/General Communicable Disease Control - Tuberculosis (TB) Elimination." Total funding will be $53,830.
Allison Ashley-Koch of Nephrology has received an award (1R21-AG084916-01A1) from the National Institutes of Health for a project entitled "'Omics predictors of Sickle Cell Severity and Survival." Total funding will be $430,956.
Brent Hanks of Oncology has received a sub-award (D-2024-015) through the V Foundation for Cancer Research for a project entitled "Role of mregDC-PCSK9-mediated Inhibition of DC Antigen Cross-Presentation in Tumor Immunotherapy Resistance." Total funding will be $350,000.
Megan Clowse of Rheumatology has received an award (1K24-AR084072-01) from the National Institutes of Health for a project entitled "Advancing Reproductive Rheumatology through Research Mentoring." Total funding will be $849,824.
Shannon M. Herndon (Mentor: David Leverenz) of Rheumatology has received an award from the Rheumatology Research Foundation for a project entitled "Patient Perspectives on Palliative Care in Rheumatology." Total funding will be $15,000.
Industry Sponsored Clinical Trials
Adam Devore of Cardiology has received an award from Ventricle Health, Inc. for a project entitled "Elevate-HF." Total funding will be $936,101.
Neha Pagidipati of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "V-INCLUSION." Total funding will be $9,066,878.
Sudarshan Rajagopal of Cardiology has received an award from GB002, Inc. for a project entitled "GBT002-3102 PROSERA-EXT Pro00115550." Total funding will be $131,935.
Yubin Kang of Cell Therapy has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458;anti-BCMA x anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients with Relapsed/Refractory Multiple Myeloma (LINKER-." Total funding will be $925,187.
Thomas Leblanc of Cell Therapy has received an award from Welch Allyn, Inc. for a project entitled "Disco Thermometer Engineering Study Protocol No.: 60117201." Total funding will be $39,050.
Chenyu Lin of Cell Therapy has received an award from Incyte Corporation for a project entitled "Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft versus Host Disease." Total funding will be $285,613.
Chenyu Lin of Cell Therapy has received an award from Rigel Pharmaceuticals, Inc. for a project entitled "Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft versus Host Disease." Total funding will be $175,048.
Vance Fowler of Infectious Diseases has received an award from Research of Technologies and Biophotonics LTD for a project entitled "Proof of Principle Study." Total funding will be $460,817.
Michael Harrison of Oncology has received an award from ProfoundBio US Co. for a project entitled "Phase 1/2 Study of PRO1160 in Patients with Metastatic Renal Cell Carcinoma (RCC), Metastatic or Relapsed Nasopharyngeal Carcinoma (NPC), or Advanced (Stage III or IV) Non-Hodgkin Lymphoma (NHL)." Total funding will be $461,937.
Christopher Hoimes of Oncology has received an award from Xencor, Inc for a project entitled "A Phase 1, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of XmAb®662 in Monotherapy or in Combination with Pembrolizumab in Advanced Solid Tumors." Total funding will be $25,955.
Niharika Mettu of Oncology has received an award from Jazz Pharmaceuticals for a project entitled "A Phase 1, first-in-human, open-label, multicenter study of JZP898 as monotherapy and in combination with pembrolizumab in participants with advanced or metastatic solid tumors." Total funding will be $1,292,353.
Ankoor Shah of Rheumatology has received an award from Cabaletta Bio, Inc. for a project entitled "A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis." Total funding will be $2,269,918.
Teresa Tarrant of Rheumatology has received an award from Horizon Therapeutics Ireland DAC for a project entitled "HZNP-DAZ-303: A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dazodalibep in participants with Sjogren's syndrome with moderate-to-severe symptom state." Total funding will be $297,663.